Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2014


To view an abstract, select an author from the vertical list on the left.

2014 Grants - Ripoli

Intraneuronal Binding Partners of Amyloid-Beta Protein

Cristian Ripoli, Ph.D.
Universitá Cattolica del Sacro Cuore
Rome, Italy

2014 New Investigator Research Grant

Amyloid-beta (also known as beta-amyloid) is a protein fragment that plays an important role in Alzheimer’s disease. Beta-amyloid fragments can accumulate into clumps called amyloid plaques, a hallmark of Alzheimer’s disease. Research on the effects of beta-amyloid in the brain have primarily focused on how it impairs nerve cell function and causes nerve cell toxicity by binding to proteins on the outer surface of the cells. However, there is also evidence that beta-amyloid can accumulate inside of nerve cells.

Cristian Ripoli, Ph.D., and colleagues have been studying how the accumulation of beta-amyloid inside of nerve cells may affect cell function. They have observed that when beta-amyloid aggregates inside nerve cells, it can lead to impairments in synaptic transmission. Synaptic transmission is the process by which nerve cells communicate with one another, giving the brain many of its unique properties, including the ability to learn and remember.

Dr. Ripoli and colleagues have proposed to explore the mechanisms by which beta-amyloid can impair synaptic transmission from inside nerve cells. They will study a number of proteins important in synaptic transmission to determine which ones bind to beta-amyloid and how they are affected by that binding. These studies may reveal new insights into how beta-amyloid impacts nerve cell function and suggest novel ways to prevent or slow the progression of Alzheimer’s disease.


Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.